NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 20 filers reported holding NEPHROS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $67 | -4.3% | 45,341 | 0.0% | 0.04% | -2.2% |
Q2 2023 | $70 | +29.6% | 45,341 | -9.9% | 0.04% | +25.0% |
Q1 2023 | $54 | -6.9% | 50,341 | 0.0% | 0.04% | -10.0% |
Q4 2022 | $58 | -99.9% | 50,341 | 0.0% | 0.04% | +21.2% |
Q3 2022 | $46,000 | -11.5% | 50,341 | +48.1% | 0.03% | 0.0% |
Q2 2022 | $52,000 | -50.0% | 34,000 | +43.4% | 0.03% | -41.1% |
Q1 2022 | $104,000 | +15.6% | 23,712 | +56.0% | 0.06% | +9.8% |
Q4 2021 | $90,000 | +20.0% | 15,200 | +78.8% | 0.05% | +13.3% |
Q3 2021 | $75,000 | -12.8% | 8,500 | 0.0% | 0.04% | -15.1% |
Q2 2021 | $86,000 | -7.5% | 8,500 | -39.4% | 0.05% | -8.6% |
Q1 2021 | $93,000 | -24.4% | 14,019 | -1.9% | 0.06% | -29.3% |
Q4 2020 | $123,000 | +7.9% | 14,290 | -9.0% | 0.08% | -7.9% |
Q3 2020 | $114,000 | +4.6% | 15,700 | +21.2% | 0.09% | +4.7% |
Q2 2020 | $109,000 | +32.9% | 12,957 | 0.0% | 0.08% | +25.0% |
Q1 2020 | $82,000 | +39.0% | 12,957 | +119.3% | 0.07% | +100.0% |
Q4 2019 | $59,000 | – | 5,908 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEXFORD CAPITAL LP | 3,657,465 | $5,669,071 | 1.13% |
BARD ASSOCIATES INC | 192,939 | $299,056 | 0.12% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,341 | $70 | 0.04% |
GEODE CAPITAL MANAGEMENT, LLC | 77,344 | $119,883 | 0.00% |
STATE STREET CORP | 15,698 | $24,332 | 0.00% |
MORGAN STANLEY | 15,292 | $23,703 | 0.00% |
BLAIR WILLIAM & CO/IL | 36,249 | $56,186 | 0.00% |
BlackRock Inc. | 4,131 | $6,403 | 0.00% |
HighTower Advisors, LLC | 56,710 | $89,000 | 0.00% |
Tower Research Capital LLC (TRC) | 554 | $859 | 0.00% |